![Christopher Beattie](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Christopher Beattie
Public Communications Contact bei
BLACKROCK CAPITAL INVESTMENT CORPORATION
Profil
Christopher Beattie is currently working as a Press Contact at BlackRock Capital Investment Corp.
Prior to this, he worked as a Director-Clinical & Regulatory Affairs at Onyvax Ltd. and as a Principal at Xenova Group Plc.
Aktive Positionen von Christopher Beattie
| Unternehmen | Position | Beginn |
|---|---|---|
| BLACKROCK CAPITAL INVESTMENT CORPORATION | Public Communications Contact | - |
Ehemalige bekannte Positionen von Christopher Beattie
| Unternehmen | Position | Ende |
|---|---|---|
Xenova Group Plc
 Xenova Group Plc Miscellaneous Commercial ServicesCommercial Services Researches and develops pharmaceutical products | Corporate Officer/Principal | - |
Onyvax Ltd.
 Onyvax Ltd. Miscellaneous Commercial ServicesCommercial Services Develops cancer remedy therapies | General Counsel | 31.05.2012 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
4
Beziehungen ersten Grades
3
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
Xenova Group Plc
Xenova Group Plc Miscellaneous Commercial ServicesCommercial Services Researches and develops pharmaceutical products | Commercial Services |
BlackRock Capital Investment Corp
 BlackRock Capital Investment Corp Investment ManagersFinance Operates as a closed-end management investment company | Finance |
Onyvax Ltd.
Onyvax Ltd. Miscellaneous Commercial ServicesCommercial Services Develops cancer remedy therapies | Commercial Services |
